Senate Moves Pay-for-Delay Ban But Has Work Ahead for Full Passage

July 22, 2011
A recent import alert for a Dr. Reddy’s Mexico facility could cost the company about $30 million over the course of the year as it prepares to launch 10 generic products in the U.S.
Drug Industry Daily